Erianin mitigates diabetic cardiomyopathy <i>via</i> adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation
Erianin can effectively alleviate myocardial injury in type 2 diabetic mice by activating the AMPK-Nrf2-HO-1 pathway.
Authors
- Xuming Dai (ORCID: https://orcid.org/0000-0003-3092-9323)
- Zijiao Quan
- Jiahui Chen (ORCID: https://orcid.org/0000-0001-5416-6231)
- Xinyu Liu (ORCID: https://orcid.org/0000-0002-0564-7167)
Institutions
- Wenzhou University (CN)
- Wenzhou Medical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-06-13
- DOI
- https://doi.org/10.4239/wjd.v16.i6.103685
- Citations
- 1
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.39